Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer

INTRODUCTION: Inhibitor of apoptosis (IAPs) proteins are a family of proteins that can block apoptosis in normal cells and have been suggested to cause resistance to apoptosis in cancer. Overexpression of oncogenic receptor tyrosine kinases is common in breast cancer; in particular 20% of all cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Fiona M, Owens, Thomas W, Tanianis-Hughes, Jolanta, Clarke, Robert B, Brennan, Keith, Bundred, Nigel J, Streuli, Charles H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716510/
https://www.ncbi.nlm.nih.gov/pubmed/19563669
http://dx.doi.org/10.1186/bcr2328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716510/
https://www.ncbi.nlm.nih.gov/pubmed/19563669
http://dx.doi.org/10.1186/bcr2328

Ejemplares similares